The first mammalian molecules shown to be involved in innate immune recognition of, and defense against, microbial pathogens are the Toll-like receptors (TLRs), which constitute the main sensors for detection of extracellular microbes [ 1].
Instead, as for many other microbial pathogens, multiple factors likely contribute to pathogen subversion of immune signaling.
Anesthesia and aseptic methods in surgery were developed during this period, and the emergence of germ theory through work of Pasteur, Koch, and others made it possible to identify the microbial pathogens that cause common diseases like whooping cough, syphilis, and cholera (Porter 1998; Gluckman et al. 2009).
Microbial pathogens activate the innate immune system by engaging Toll-Like Receptors (TLRs), resulting in cytokine release and the upregulation of costimulatory molecules on antigen-presenting cells.
Ozato et al. [ 48] described the response of cell-surface toll-like receptors (TLRs) upon binding to microbial pathogens.
Furthermore, the virulence mechanisms of microbial pathogens, especially of environmental opportunistic pathogens, are likely conserved among different hosts as these pathogenic microbes often have evolved and maintained their virulence through interactions with a diverse range of environmental predators like amoeba or nematodes [4] [7].
Dectin-1 collaborates with toll-like receptor 2 in inflammatory responses against microbial pathogens [20].
Tumour necrosis factor- α secretion can be induced by conserved structural elements common to microbial pathogens, such as lipopolysaccharide (LPS), that are bound by Toll-like receptors (TLRs) (Aderem and Ulevitch, 2000).
Toll-like receptors (TLRs) play a central role in detecting microbial pathogens.
These vaccines elicit antibody responses against the drug molecules, just like traditional vaccines evoke antibody responses against microbial pathogens.
